Upcoming Webinar: Optimizing PrEP in Practice: Guidelines & Clinical Considerations (March 24)
Posted March 5, 2022
Description
How do the latest CDC’s Clinical Practice PrEP Guidelines affect you, your patients, and your practice?
PrEP is a vital tool in our efforts to End the HIV Epidemic in the US. In December 2021, CDC published the Clinical Practice Guideline for Preexposure Prophylaxis for HIV Prevention and Clinical Providers Supplement. This document serves as a guidepost for data-driven PrEP delivery and reflects the latest evidence and FDA guidance for PrEP prescribing, the policy implications on newly FDA-approved long-acting products, and the multiple ways in which patients are on-boarded into the PrEP intervention system.
Join Dr. Demetre Daskalakis, CDC’s Director of the Division of HIV Prevention, on Thursday, March 24, 2022 at 1:00pm EDT at as he delves into these clinical guidelines and reviews the latest PrEP science. Following his presentation, Dr. Anu Hazra will speak to the clinical considerations of the guidelines from a PrEP provider standpoint, followed by a moderated Q & A session with both faculty.
FREE continuing education credits are available for this session!
Topics to be covered:
- Overview of the Clinical Practice Guideline for Preexposure Prophylaxis for HIV Prevention and Clinical Providers Supplement
- Increasing PrEP access to meet Ending the HIV Epidemic (EHE) goals
- Prescribing PrEP and cost-sharing concerns
- The clinical implications of the guidelines
- Resources for providers and their patients
Thursday, March 24, 2022 at 1:00pm EDT
Learning Objectives
At the conclusion of this activity, learners will be able to…
- Identify the updates in the PrEP Clinical Practice Guideline.
- Understand the latest epidemiological PrEP data.
- Describe how the guidelines align with the Ending the HIV Epidemic in the U.S. initiative.
- Indicate strategies for implementing the recommendations in clinical practice.
Audience
Clinicians/providers prescribing, dispensing, or administering PrEP (MD, DO, PA, NP, PharmD); allied healthcare professionals (Nurse, MSW, PrEP navigators); administrators, PrEP and healthcare policy advocates.
Credits Offered
1.0 Continuing Education Credits (CME, MOC, NCPD, CE, and IPCE)
Agenda (All times Eastern)
- 1:00pm – 1:25pm: Dr. Demetre Daskalakis speaks to the Clinical Practice Guideline for Preexposure Prophylaxis for HIV Prevention and Clinical Providers Supplement and EHE.
- 1:25pm – 1:40pm: Dr. Anu Hazra speaks to the FAQs in practice and the provider’s role in implementation.
- 1:40pm – 2:00pm Conversation and questions with Dr. Daskalakis and Dr. Hazra, moderated by Matthew Prior.
About the Speakers
Dr. Daskalakis serves as the Director of CDC’s Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention. He is recognized nationally and internationally as an expert in HIV prevention and has focused much of his career on the treatment and prevention of HIV and other STIs as an activist physician with a focus on LGBTQIA+ communities.
Dr. Hazra is an Assistant Professor of Medicine in UChicago Department of Medicine’s Section of Infectious Diseases and Global Health. His research and clinical interests center around STIs and their impact on gender and sexual minorities. His other clinical interests include complex HIV management, hepatitis C treatment, high resolution anoscopy, treatment of opioid use disorder, and medical education.
